Delivery Order SPE2DB22D2206-SPE2DB25FJV16
- Not listed
- The Defense Logistics Agency awarded a $9,522 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ZYNRELEF 200-6 mg/7 ml vials. This non-competitive, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ZYNRELEF 200-6 MG/7 ML VIAL 7ML pharmaceutical product, with a ceiling value of $1,744.77. The contract is a firm fixed-price delivery order with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $1,442.70 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ZYNRELEF 200-6MG/7 1S medical products, with a performance period ending on June 24, 2025. The award is not set-aside and was made on May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,777.20, is for the delivery of ZYNRELEF 400-12 MG/14 ML VIAL 14ML, a pharmaceutical product. The contract has a completion date of February 3, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- The U.S. Defense Department's Medical Supply Chain awarded a $9,287.25 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, a specialty pharmaceutical product used in pain management. This firm fixed-price, competitively awarded contract was executed on September 3, 2025, with completion scheduled for September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen (2-pack units) on August 5, 2025, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $4,457.88 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, awarded on August 4, 2025, represents a non-set-aside competitive procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zilretta 32 mg vials, an intra-articular corticosteroid injection used for osteoarthritis pain management. This firm fixed-price delivery order, which carries an ultimate completion date of September 30, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,287.25 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, for the supply of Zilretta 32 mg vials. The competitively awarded, firm fixed-price contract carries an ultimate completion date of September 8, 2025, and involves performance at the vendor's Conshohocken facility. This delivery order represents a child contract...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV16Delivery Order
The Defense Logistics Agency awarded a $5,127.41 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for ZYNRELEF 400-12 mg/14 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded. ZYNRELEF is a liposomal bupivacaine and meloxicam combination product used for local infiltration anesthesia and pain management during surgical procedures, representing a specialized pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Logistics Agency's medical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contracting demonstrates substantial capability in fulfilling competitive procurement requirements, delivering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/8/25 |